The oat beta-glucan market was valued at USD 620 million in 2025, is projected to reach USD 1,560 million by 2036 and is forecast to register an 8.5% CAGR between 2026 and 2036. In 2026, cholesterol management holds 31.0% of claim focus demand and concentrates represent 30.0% of product format sales.